The pharmaceutical industry is rapidly embracing real-world evidence (RWE) to accelerate drug development and regulatory approvals. External control arms (ECAs), built using real-world data (RWD), are transforming clinical trials by offering an alternative to...
research
From Symptom to Strategy: What Itch Intensity Data Tells Us About Pruritus Management
Pruritus, or chronic itch, is one of the most common symptoms reported in dermatology, yet real-world treatment patterns remain poorly characterized. While topical therapies are typically the first-line approach, severe cases often require systemic interventions. But...
Advancing SDoH research with unstructured clinical notes to improve patient care
Every patient’s story extends beyond structured medical records. Social determinants of health (SDoH), such as economic insecurity, often go unrecorded in traditional coding systems, leaving critical gaps in understanding patient needs. A recent study utilizing OMNY...
Why Clinical Measures Matter: Linking Disease Activity to Treatment Decisions in Actinic Keratosis
In dermatology, real-world data plays a crucial role in understanding disease progression and optimizing treatment strategies. Actinic keratosis (AK), a common precancerous skin condition, requires tailored management approaches based on disease severity. OMNY...
OMNY Health Launches Dynamic GLP-1 Network of 600,000+ Patients to Fuel Clinical Research on Its Use
New Studies on the Use of These Medications in Adult and Pediatric Populations are Supported by the Data NetworkAtlanta, Georgia – August 27, 2024 – OMNY Health, the leading healthcare ecosystem known for facilitating compliant cross-industry data partnerships, today...